Gabrielsen E, Wilsgaard T, Frydenberg H, Lofterød T, Dalen SM, Mortensen E, Solbu MD, Nalwoga H, Akslen LA, Blix ES, Haugnes HS(2025) Higher pre-diagnostic serum syndecan-4 levels are associated with increased breast cancer risk: a case-cohort study Breast Cancer Res Treat(in press) DOI 10.1007/s10549-025-07786-4, PubMed 40694191
Skourti E, Seip K, Mensali N, Jabeen S, Juell S, Øynebråten I, Pettersen S, Engebraaten O, Corthay A, Inderberg EM, Dolznig H, Mælandsmo GM, Egeland EV, Prasmickaite L(2025) Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer Breast Cancer Res, 27(1), 131 DOI 10.1186/s13058-025-02082-x, PubMed 40660361
Johansen SH, Sæter M, Sarvari SI, Reinertsen KV, Edvardsen E, Wisløff T, Scott JM, Grydeland M, Raastad T, Hallén J, Kiserud CE, Lie HC, Solberg PA, Haugaa KH, Jensen JSS, Vatningen LH, Thorsen L, Nilsen TS(2025) Effects of Aerobic Exercise on Cardiorespiratory Fitness and Cardiovascular Risk Factors in Long-Term Breast Cancer Survivors: A Randomized Controlled Trial JACC CardioOncol, 7(4), 414-426 DOI 10.1016/j.jaccao.2025.04.006, PubMed 40537190